The Filing Desk

ImmuCell vs RxSight

ImmuCell ICCC · RxSight RXST · Health Care Supplies

RxSight reported revenue of $134 million in fiscal 2025, 4.9 times ImmuCell's $28 million in fiscal 2025. ImmuCell's revenue grew 4.3% in its latest year, and RxSight's fell 3.9%. ImmuCell had an operating margin of 6.0%, against -35.8% at RxSight. Free cash flow was $1 million at ImmuCell and −$19 million at RxSight.

Side by side

ImmuCellRxSight
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$28M$134M
Revenue growth4.3%−3.9%
Revenue growth a year, last 5 years12.5%55.7%
Gross margin41.4%76.6%
Operating margin6.0%−35.8%
Net margin−3.8%−29.0%
Free cash flow$1M−$19M
Free cash flow margin4.4%−14.4%
Return on capital—−82.9%
Net debt to EBITDA1.2x—
Dividends and buybacks$0M$0M
Change in diluted share count10.5%5.1%
Last close$11.17$4.61
P/E at the last close58.8×—
Insider trades, last 12 monthsbought $140,146, sold $0sold $103,745
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ImmuCellRxSight
Operating margin
Percent of revenue
ImmuCellRxSight
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ImmuCellRxSight

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the ImmuCell and RxSight pages.